Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 12073191000202111 | Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 12073201000202113 | Clindamycin (as clindamycin phosphate) 12 mg/mL solution for infusion | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5981311000052118 | klindamycin (som klindamycinfosfat) 12 mg/ml, infusionsvätska, lösning | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Is a | Product containing only clindamycin in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Has manufactured dose form | Solution for infusion | true | Inferred relationship | Some | ||
| Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Has precise active ingredient | Clindamycin phosphate | true | Inferred relationship | Some | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Has basis of strength substance (attribute) | Clindamycin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR